Select Committee on European Union Minutes of Evidence


Examination of Witnesses (Questions 120 - 139)

THURSDAY 13 DECEMBER 2007

Mr Chris Rudge, Mr Gareth Jones and Ms Triona Norman

  Q120  Lord Lea of Crondall: In my case, I have a donor card and we are members of the EU. In the European Commission document—which, if I may say, so is rather well written, carefully considered, has some very good benchmarks in it—is there not going to be some prima facie advantage—not being just dog in a manger about it—of seeing how it can be endorseable like my driving licence? My driving licence is not ipso facto a European driving licence but it has a European validity, has it not?

  Mr Rudge: I can happily go along with the view that your views, as represented in this country, should equally be valid in any other European country. That is the principle you are stating and I would absolutely go along with it. I cannot go along with introducing yet another way of recording your wishes. We already have a very good way of recording wishes in this country. People know about it. Fifteen million people have put their name on the Organ Donor Register. Why confuse them with yet another thing.

  Lord Lea of Crondall: I am sorry, but we need analysis of what we would do to make it work.

  Q121  Chairman: With respect, Lord Lea, we are going to have to move on because time has moved on and we have a lot to cover. I think Mr Rudge is suggesting that we are not at that stage in terms of different European legislation in different countries and that the wishes you might have expressed might not be the ones you find are being carried out if you find yourself in another country.

  Mr Rudge: I think there is a risk of that.

  Q122  Chairman: We have not reached that stage in Europe yet.

  Mr Rudge: I think there is a risk of people perceiving that that is thought to be the case.

  Q123  Chairman: And perception is a large part of what is going to happen.

  Mr Rudge: A very large part, yes.

  Chairman: Could we move on to Lady Gale.

  Q124  Baroness Gale: My question is on improving the supply of organs for transplantation. Bearing in mind the much higher organ donation rate there is in Spain than there is in the UK, what is your view of the relative importance for improving the supply of organs for transplantation of (a) improving organ donation and transplantation services and (b) switching from a system of opting in to opting out or presumed consent? If improvements are to be made to organ donation and transplantation services, what new requirements do you think there should be for professional training?

  Mr Rudge: Spain does have an organ donation rate that is unique in the world. Nowhere else in the world comes close to matching the Spanish donation rate, although Northern Italy and one or two other areas of South America have made quite marked improvements in recent years based on implementing the Spanish model. What is more important than what I think is what Rafael Matesanz thinks. Rafael was the architect of the Spanish model. He was appointed in 1989 and in 1989 Spain had the same organ donation rate as this country did. Now it has a donation rate that is three times greater. I have worked very closely with Rafael Matesanz. I write chapters with him. I have the embarrassing difficulty of speaking at meetings immediately after him, so he describes the Spanish success and then I have to describe the UK's failure. Rafael would say himself, and has said in writing and in public, that it is the Spanish system and structure and model that is important and not the law. The law in Spain was exactly the same in 1989—when they had the same organ donation rate as we did—as it is today. The changes that have occurred in Spain, the threefold/two-and-a-half-fold increase in organ donation in Spain, have occurred without changing the law. They occurred because Rafael changed the system. He did all the things I mentioned earlier. He changed how they identify potential donors and notify them to the co-ordinators—the right number of co-ordinators in the right way, with the right amount of time and the right experience—and everything else I have already mentioned. There are one or two other comments, while we mention Spain. I would emphasise this point that I believe it is the structure rather than the law. Spain pro rata has three times as many intensive care beds as we have in this country and it has three times as many donors pro rata. Spain has three times as many organ donor co-ordinators as we do in this country and it has three times as many organ donors. I do not think those two things are a coincidence. I think the law clearly plays a part. I would not for a second understate that but I do not think anything will be achieved until the system is right and I do not believe we have the right system in this country.

  Q125  Chairman: You are painting a very clear picture that structure plays a very important part. I am going to move on now because time is moving on.

  Mr Rudge: Perhaps I could very quickly say, My Lord Chairman, that there is a great need for training. I think it is already available and can be improved and implemented. I do not think it is a restricting factor.

  Chairman: Lady Young is going to deal now with organ trafficking.

  Q126  Baroness Young of Hornsey: You have already alluded to organ trafficking. How serious do you think the problem of organ trafficking is across the EU? Do you envisage that there is a role at the EU level to monitor and combat any growth in the problem of organ trafficking? If it is not a substantial problem in the EU, do you see any other issues arising out of donation tourism and/or cross-border donation? I would also be interested to know whether you feel there is a qualitative distinction to be made between trafficking and tourism?

  Mr Rudge: I would agree that within the European Union people trafficking for organ donation is a very minor issue in terms of numbers and activity. I am not aware that it happens at all within the European Union. I am very well aware that it happens elsewhere in the world. I think it is clearly unacceptable. As Triona has already said, virtually every EU country has legislation that prohibits organ trafficking. Several of us have worked very closely with the World Health Organisation over recent years and months and the World Health Organisation's guiding principles set out very clearly that organ trafficking and so on are unacceptable and provide a strong framework for other countries to work within. It is essential that we do not drop our guard because I do believe organ trafficking is a horrible thing. It is very important for countries to have appropriate legislation and appropriate monitoring systems to ensure that it is not happening. The experience varies across the EU. Obviously some of the more recent countries have had less experience of this sort of legislation and these sorts of monitoring processes. I think the EU can play a role in spreading good and correct practice, both in legal terms and in structural terms, to monitor what happens.

  Q127  Chairman: What about this distinction between tourism and trafficking?

  Mr Rudge: I think we could spend a long time discussing whether there is a difference or not. Some patients from this country travel to other countries for a transplant quite legitimately and properly because that is where their families come from. I have worked for many years in the East End of London where there are very large Bangladeshi and Pakistani populations. Those patients who are resident in this country have families in Asia and they travel to Asia to have a kidney transplant from their brother or sister or mother and father, and that is all right and proper. I do not really call that transplant tourism. I call that right and proper, good medicine, but it happens to be patients from different countries having a transplant.

  Q128  Chairman: We have heard of people arriving in this country and then having to have treatment for what are poor quality organs. Do you have any evidence of that? What are the consequences of it?

  Mr Rudge: I have a limited amount of hard evidence and I have some personal experience. The hard evidence is that UK Transplant asks all the transplant programmes in this country to register with us the patients who have originated in this country, gone abroad for a transplant and then returned to this country for their follow-up care. We receive between 20 and 30 registrations a year. I cannot guarantee that that is comprehensive, because I do not know of the patients who are not registered with us and we have no way of enforcing that, but I believe it is pretty reasonable. Twenty or 30 patients a year go abroad, have a transplant and come back to this country. The outcome for those patients is marginally less good than it is for patients who have a transplant in this country but not dramatically so. But of course I am only referring to those patients who go abroad, have their transplants, survive and then come back to this country. I do not have any information about individuals who go abroad and have an unsuccessful transplant and perhaps die and therefore do not come back.

  Q129  Chairman: It is not a huge problem.

  Mr Rudge: It is not a huge problem. Personally I see these patients in the clinic that I do in the Royal London Hospital every Tuesday morning. They do very well actually, if the truth be known. The problems associated with this sort of transplantation are real but they can be exaggerated.

  Q130  Baroness Young of Hornsey: The next question is about raising public awareness and ethical concerns about organ donation. To what extent do you think that measures to increase public awareness and knowledge could be effective in getting more people willing to place themselves on the register? Which measures do you think might be the most effective?

  Mr Rudge: Awareness of organ donation amongst the public is crucial. There are currently nearly 15 million people who have put their name on the Organ Donor Register and that number is rising by over one million a year, but of course it is still only representative of 25% of the population. As with everything, there is a lot that can be done without spending enormous amounts of money on advertising but large amounts of money spent on advertising are important. I think we need to make it easier for people to put their names on the Organ Donor Register. We are forever trying to come up with ways of making it easier. People can put their names on when they have a driving licence, when they change their general practitioner, when they get an Advantage Card from Boots, and in a wide range of other ways, but we are always looking for more ways of making it easier. Media interest undoubtedly has an effect. It has a short-term sudden effect. Sir Liam's report and the publicity surrounding it in the summer had an effect. I think we need to work more with schools. UK Transplant and NHS Blood and Transplant launched a schools educational pack in September this year called Give and Let Live. That has been made available to secondary schools. About 1,000 schools so far have taken up that offer and I think more are doing it all the time. I think it is a very wide-ranging question and there is not one answer. I think every possible way of raising awareness of organ donation and the need for transplantation has to be grasped. Some of that can be done relatively easily, some requires money.

  Q131  Lord Trefgarne: We are anxious to ascertain in the course of our inquiry the expert's view on when death occurs and therefore after which it is proper to take the organ. We did talk to Sir Liam about this last week but we would be grateful to hear your view, particularly as you yourself have been a transplant surgeon. Are there any circumstances when we do not take an organ, even from a consenting patient; for example, very ill patients?

  Mr Rudge: Yes. The criteria for the diagnosis of death, either by brain-stem death tests or after the heart and respiration have ceased, are crystal clear. They are published in the intensive care society guidelines and the Academy of the Royal Medical Colleges is about to update their existing guidance on the diagnosis of death. I do not believe there is any uncertainty about knowing whether somebody is dead or not.

  Q132  Lord Trefgarne: Would we understand that documentation or some of it? Could we see it?

  Mr Rudge: I can provide it for you. It is technical. Let me answer your question in another way. In practice it is really the family of the organ donor who have to be satisfied the person is dead. They understand that. They say to me, "He died two days ago when his car hit the tree." They know the person is dead. But increasingly they are being taken along to the bedside when the tests that are carried out are being carried out. They see the body not breathing when it is disconnected from the ventilator; they see that the eyes are dead; they see that there is no response to anything. It is like looking at a doll. Families see that and families understand that that person is dead.

  Q133  Chairman: Does that answer your question?

  Mr Rudge: It is a short answer because of time.

  Q134  Lord Trefgarne: I accept what you say about that because I had the same with my mother back in the summer. She was too old but she wanted to give her organs.

  Mr Rudge: The answer is that there are clearly criteria that allow organs to be suitable or not suitable. It depends on the organs. Age is one of them. Things like HIV, CJD, cancer, other infections may or may not make the organs suitable or not.

  Q135  Baroness Young of Hornsey: There is an important question on this issue of the mismatch between the supply and demand of organs particularly for black and other ethnic minority groups. I am wondering why there is that mismatch, because it is so significant. What is it possible to do in terms of preventative work with those communities? What is it possible to do in terms of working with those communities to lower that disparity? Are there issues across the EU with other ethnic minority groups and what actions, in general, do you think could be taken to address this situation? I am aware of the time, so perhaps if we are not able to address this all today you could write in.

  Mr Rudge: I certainly will. Perhaps I could give you three or four little bits of information and then Triona may want to say something also. At the moment 23% of the people who are waiting for a kidney transplant are from black and minority ethnic backgrounds; approximately 8% or 9% of the population are from that background and only 3% of organ donors come from that background. There is a clear mismatch. Why are so many people on the waiting list for a transplant? Sadly, the incidence of kidney failure is three or four times greater in patients from an Afro-Caribbean, African or Asian background than it is amongst Caucasian patients, so the need is three or four times greater. That is an absolute problem, because, even if the donation rate were the same amongst the groups, the need is three or four times greater. However, it is even worse than that because the donation rate is low. It is low because if the potential donor is—and forgive me for being so simplistic—white, 35% of the relatives refuse consent for organ donation. If the potential donor is from any other background, other than white, 75% of the relatives refuse consent for donation. There are not enough donors from those groups and there are far more patients who need transplants from those groups, so the gap is enormous.

  Q136  Baroness Young of Hornsey: Why are there so many more instances of kidney failure? Is there a quick answer to that or is it very, very complex?

  Mr Rudge: It is complex. It is the subject of a lot of work and a lot of research and a lot of thing in preventative medicine in particular. There is a group in north-west London who are doing all sorts of things out in the community, trying to get people walking down the street to have their blood pressure measured or their urine tested for protein.

  Q137  Baroness Young of Hornsey: Is it blood pressure? Lifestyle?

  Mr Rudge: It is blood pressure and diabetes.

  Q138  Lord Lea of Crondall: Presumably under the opt-out possibility there is a reduction in this mismatch of people saying, "I don't want my kidney to go there." Would that be logically an inference you would draw? How would the scheme work if that would not be a reasonable inference?

  Mr Rudge: I am sorry, I am not entirely sure I understood your inference.

  Q139  Lord Lea of Crondall: The inference being that the difference between 25% who say, "I am happy for my kidney going to a white person" but 75%—

  Mr Rudge: No, I am sorry, I did not say that.


 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2008